Company intelligence / Profile preview

Robeauté

Ownership: Private
Development stage: Preclinical

Overview

Robeauté has developed a microrobot the size of a grain of rice capable of navigating the brain to perform advanced biopsies, deliver drugs, implant electrodes, and collect real-time data. The technology is currently in animal studies as a biopsy tool; human clinical trials are being prepared pending regulatory approval. Over 50 patents have been filed. The company recently raised $28 million to advance toward FDA approval and expand operations.

Therapeutic areas: OncologyNeurology
Modalities: DeviceDrug delivery device (potential for targeted therapy delivery)Biopsy tool (device)
Industry: Surgical Medical Devices

Partnerships

Brainlab (digital neurosurgery & precision radiotherapy partner)

Beyond the preview

Go deeper on Robeauté.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Robeauté.

Explore the full profile